In an amazing update, it was reported that the DRDO Antiviral Drug 2-DG was administered to patients in critical condition and they showed good results. These patients were on oxygen support but after being given the DRDO drug, they were off the support.
Patients are recovering well after being given the drug. Medical experts believe this to be a gamechanger in the Covid fight. In the latest report it was said that out of all those given the drug, around 42% of patients were off the oxygen support.
The Defence Research and Development Organisation (DRDO) Chairman, Dr G Satheesh Reddy mentioned that the anti-Covid drug will be available to all those who need it. He stated that the drug will provide relief to thousands of people who are struggling due to the infection.
The Drugs Controller General of India (DCGI) had approved the 2-DG drug developed by DRDO's Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad, for emergency use.
“2-DG accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique,” Dr Satheesh Reddy said.
During the third phase of clinical trials, more than 51 per cent of the patients were cured within three days, he said, and others within 5 to 7 days after administering the drug, which can be used for moderate to severe Covid patients. This comes as a significant relief to the medical officials and hospitals who are running out of oxygen cylinders.
Dr Satheesh Reddy told that DRDO is coming out with lightweight oxygen gas cylinders with a regulator and non-returnable valve with features to save oxygen. He stated that those would be useful for those who are in home isolation.
The first batch of Covid-19 drug 2-deoxy-D-glucose (2-DG) oral drug was released on Monday, May 17th by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. It has already started showing favourable results.